| Hans-Günter Meyer-Thompson | International
Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?
Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?
Russell C, Lange S, Kouyoumdjian F, Butler A, Ali F.
Harm Reduct J. 2022 Aug 10;19(1):89. doi: 10.1186/s12954-022-00671-z. PMID: 35948961; PMCID: PMC9363267.
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00671-z